Author:
Kyle R A, ,Durie B G M,Rajkumar S V,Landgren O,Blade J,Merlini G,Kröger N,Einsele H,Vesole D H,Dimopoulos M,San Miguel J,Avet-Loiseau H,Hajek R,Chen W M,Anderson K C,Ludwig H,Sonneveld P,Pavlovsky S,Palumbo A,Richardson P G,Barlogie B,Greipp P,Vescio R,Turesson I,Westin J,Boccadoro M
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference23 articles.
1. International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 2003; 121: 749–757.
2. Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Offord JR et al. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med 2006; 354: 1362–1369.
3. Cohen HJ, Crawford J, Rao MK, Pieper CF, Currie MS . Racial differences in the prevalence of monoclonal gammopathy in a community-based sample of the elderly.[erratum appears in Am J Med 1998 Oct;105(4):362]. Am J Med 1998; 104: 439–444.
4. Singh J, Dudley Jr AW, Kulig KA . Increased incidence of monoclonal gammopathy of undetermined significance in blacks and its age-related differences with whites on the basis of a study of 397 men and one woman in a hospital setting. J Lab Clin Med 1990; 116: 785–789.
5. Landgren O, Katzmann JA, Hsing AW, Pfeiffer RM, Kyle RA, Yeboah ED et al. Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana. Mayo Clin Proc 2007; 82: 1468–1473.